Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Active-comparator Controlled, Two-Dose-level Study of iSTEP-N in Healthy Adults With Long Term Safety and PK Follow-up

NCT07064564 is registered in ClinicalTrials.gov with Akyso Therapeutics, LLC as lead sponsor.

NCT NCT07064564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07064564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Active-comparator Controlled, Two-Dose-level Study of iSTEP-N in Healthy Adults With Long Term Safety and PK Follow-up
Lead sponsor
Akyso Therapeutics, LLC
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 25, 2026
Completion date
December 31, 2029
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder